OpenVSafe by OpenVAERS
Search V-safe

6KK-16198-64373

2 vaccinations 3 coded responses 21 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
685 / NE
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-06
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-01-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Supraclavicular lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy axillary and supraclavicular
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Headache
    Free text: Lymphadenopathy- supraclavicular and axillary
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-01-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-06Pfizer-BioNTech

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-07

Systemic reaction (other): Supraclavicular lymphadenopathy

2021-01-08

Systemic reaction (other): Lymphadenopathy axillary and supraclavicular

2021-01-09

Systemic reaction (other): Lymphadenopathy- supraclavicular and axillary

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…